P6161Cardiotoxicity in haematological diseases: are the tyrosine kinase inhibitors imatinib and nilotinib safe?

2017

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

0

References

0

Citations